Cargando…
Chemically Defined, High-Density Insect Cell-Based Expression System for Scalable AAV Vector Production
The recombinant adeno-associated virus (AAV) vector is one of the most utilized viral vectors in gene therapy due to its robust, long-term in vivo transgene expression and low toxicity. One major hurdle for clinical AAV applications is large-scale manufacturing. In this regard, the baculovirus-based...
Autores principales: | Kurasawa, James H., Park, Andrew, Sowers, Carrie R., Halpin, Rebecca A., Tovchigrechko, Andrey, Dobson, Claire L., Schmelzer, Albert E., Gao, Changshou, Wilson, Susan D., Ikeda, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591331/ https://www.ncbi.nlm.nih.gov/pubmed/33145369 http://dx.doi.org/10.1016/j.omtm.2020.09.018 |
Ejemplares similares
-
Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells
por: Blessing, Daniel, et al.
Publicado: (2018) -
A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy
por: Dong, Biao, et al.
Publicado: (2013) -
Engineered CHO cells as a novel AAV production platform for gene therapy delivery
por: Nagy, Abdou, et al.
Publicado: (2023) -
T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021) -
Establishment of a Recombinant AAV2/HBoV1 Vector Production System in Insect Cells
por: Deng, Xuefeng, et al.
Publicado: (2020)